Why is Celadon Pharmaceuticals Plc ?
Unrated Stock - No Analysis Available
Quality key factors
Factor
Value
Sales Growth (5y)
3.10%
EBIT Growth (5y)
-242.99%
EBIT to Interest (avg)
-3.13
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.03
Sales to Capital Employed (avg)
0.02
Tax Ratio
4.75%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.27
EV to EBIT
-0.59
EV to EBITDA
-0.66
EV to Capital Employed
1.27
EV to Sales
3.18
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-213.95%
ROE (Latest)
-215.27%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
Bearish
Bullish
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
Bullish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Celadon Pharmaceuticals Plc
Operating Profit
Highest at GBP -2.39 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (GBP MM)
Pre-Tax Profit
Highest at GBP -2.51 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (GBP MM)
Net Profit
Highest at GBP -2.5 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is positive
Net Profit (GBP MM)
EPS
Highest at GBP -0.04
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (GBP)






